Attached files
| file | filename |
|---|---|
| EX-10.1 - EX-10.1 - Biohaven Pharmaceutical Holding Co Ltd. | a202010-kbhvnexhibit101.htm |
| EX-31.1 - EX-31.1 - Biohaven Pharmaceutical Holding Co Ltd. | a202010-kbhvnexhibit311.htm |
| EX-23.1 - EX-23.1 - Biohaven Pharmaceutical Holding Co Ltd. | a202010-kbhvnexhibit231.htm |
| EX-32.1 - EX-32.1 - Biohaven Pharmaceutical Holding Co Ltd. | a202010-kbhvnexhibit321.htm |
| EX-31.2 - EX-31.2 - Biohaven Pharmaceutical Holding Co Ltd. | a202010-kbhvnexhibit312.htm |
| EX-21.1 - EX-21.1 - Biohaven Pharmaceutical Holding Co Ltd. | a202010-kbhvnexhibit211.htm |
| 10-K - 10-K - Biohaven Pharmaceutical Holding Co Ltd. | bhvn-20201231.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-232167) and on Form S-8 (Nos. 333-233197, 333-225224 and 333-218193) of Biohaven Pharmaceutical Holdings Company Ltd. of our report dated February 25, 2020 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 1, 2021